Molecular Signaling Research Program
Normal cells have a complex series of molecular signals that allow communication between cells as well as transmittal of signals to the cell nucleus. These signals are critical for regulating cell growth, apoptosis, angiogenesis and immune avoidance of the tumor. Changes in the signaling pathways, either through mutation or changes in gene expression, are necessary for the continued growth of the tumor. An understanding of these aberrant signaling pathways, both in the tumor and in normal tissues, represent ideal targets for therapeutic intervention in translational cancer research.

Program Leader
Steven Hill, Ph.D.
Edmond & Lily Safra Chair for Breast Cancer Research
Professor and Chair of Structural and Cellular Biology
smhill@tulane.edu
(504) 988-6456, (504) 988-1687 fax
1430 Tulane Ave., Box SL-49, New Orleans, LA 70112-2699

• Asim B. Abdel-Mageed, D.V.M., Ph.D.
• Krishna Agrawal, Ph.D.
• Akira Arimura, M.D., Ph.D.
• Barbara Beckman, Ph.D.
• Matthew E. Burow, Ph.D.
• David H. Coy, Ph.D.
• W. T. Godbey, Ph.D.
• Frank Jones, Ph.D.
• Donald J. Krogstad, M.D
• Ming Li, Ph.D.
• John A. McLachlan, Ph.D.
• Charles A. Miller III, Ph.D
• Cindy Morris, Ph.D .
• Kailash N. Pandey, Ph.D.
• Brian Rowan, Ph.D.
• Suresh C. Sikka, Ph.D.
• Thomas E. Weise, Ph.D.
• William C. Wimley, Ph.D.